Evolva Holding Sa Stock Fundamentals
EVE Stock | CHF 0.85 0.01 1.16% |
Evolva Holding SA fundamentals help investors to digest information that contributes to Evolva Holding's financial success or failures. It also enables traders to predict the movement of Evolva Stock. The fundamental analysis module provides a way to measure Evolva Holding's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Evolva Holding stock.
Evolva |
Evolva Holding SA Company Current Valuation Analysis
Evolva Holding's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Evolva Holding Current Valuation | 91.22 M |
Most of Evolva Holding's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Evolva Holding SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, Evolva Holding SA has a Current Valuation of 91.22 M. This is 99.36% lower than that of the Healthcare sector and 98.04% lower than that of the Biotechnology industry. The current valuation for all Switzerland stocks is 99.45% higher than that of the company.
Evolva Holding SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Evolva Holding's current stock value. Our valuation model uses many indicators to compare Evolva Holding value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Evolva Holding competition to find correlations between indicators driving Evolva Holding's intrinsic value. More Info.Evolva Holding SA is one of the top stocks in return on equity category among its peers. It is rated # 2 in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Evolva Holding's earnings, one of the primary drivers of an investment's value.Evolva Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Evolva Holding's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Evolva Holding could also be used in its relative valuation, which is a method of valuing Evolva Holding by comparing valuation metrics of similar companies.Evolva Holding is currently under evaluation in current valuation category among its peers.
Evolva Fundamentals
Return On Equity | -0.37 | |||
Return On Asset | -0.11 | |||
Operating Margin | (2.31) % | |||
Current Valuation | 91.22 M | |||
Shares Outstanding | 1.11 B | |||
Shares Owned By Insiders | 0.66 % | |||
Shares Owned By Institutions | 25.03 % | |||
Price To Earning | (4.33) X | |||
Price To Book | 0.75 X | |||
Price To Sales | 7.35 X | |||
Revenue | 9.88 M | |||
Gross Profit | (8.81 M) | |||
EBITDA | (31.82 M) | |||
Net Income | (41.27 M) | |||
Cash And Equivalents | 11 M | |||
Cash Per Share | 0.08 X | |||
Total Debt | 3.57 M | |||
Debt To Equity | 1.60 % | |||
Current Ratio | 4.57 X | |||
Book Value Per Share | 0.10 X | |||
Cash Flow From Operations | (29.79 M) | |||
Earnings Per Share | (0.05) X | |||
Target Price | 0.28 | |||
Number Of Employees | 62 | |||
Beta | 0.71 | |||
Market Capitalization | 90.05 M | |||
Total Asset | 156.17 M | |||
Z Score | 15.0 | |||
Net Asset | 156.17 M |
About Evolva Holding Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Evolva Holding SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Evolva Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Evolva Holding SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Evolva Holding SA discovers, develops, and commercializes ingredients for use in food, nutrition, personal healthcare, agriculture, and other sectors in Switzerland, United States, Denmark, and internationally. The company was founded in 2004 and is headquartered in Reinach, Switzerland. EVOLVA N operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange. It employs 67 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Evolva Stock Analysis
When running Evolva Holding's price analysis, check to measure Evolva Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolva Holding is operating at the current time. Most of Evolva Holding's value examination focuses on studying past and present price action to predict the probability of Evolva Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolva Holding's price. Additionally, you may evaluate how the addition of Evolva Holding to your portfolios can decrease your overall portfolio volatility.